Innovation MESH Network | Mass General Brigham

Menu
a la carte ,

A la carte: BIOGEN CEO: Keeping Priority on the Biggest Diseases (WMIF)

View Course details

Biogen CEO Michel Vounatsos will discuss how Biogen is tackling some of society’s most devastating neurological and neurodegenerative disorders, and share his perspective on the impact the global COVID-19 pandemic is having on the biopharmaceutical industry. Moderator: Jean-François Formela, MD, Partner, Atlas Venture Michel Vounatsos, CEO, Biogen

Course Content

Preview this Course
Not Enrolled
Login to Enroll
Free

Course Includes

  • 1 Lesson

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .